Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
2(50.0%)
N/A
2(50.0%)
4Total
Phase 1(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04610567Phase 1Unknown

Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19)

Role: collaborator

NCT04352465Phase 1Unknown

Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients

Role: collaborator

NCT04051398Not ApplicableUnknown

Effects of Transcutaneous Nerve Electrostimulation (TENS) of Acupuncture Points on Pulmonary Function and Dyspnea Symptoms in Patients With Pulmonary Nodules

Role: lead

NCT02380378Unknown

Registry of Philadelphia-Negative Myeloproliferative Neoplasms

Role: collaborator

NCT02960464Not ApplicableUnknown

tDCS for Treatment of Depression in Parkinson's Disease

Role: lead

All 5 trials loaded